Ned Braunstein, MD; Adam Polis
Potential Financial Conflicts of Interest: Dr. Braunstein and Mr. Polis are employed by Merck & Co., Inc. and own shares of Merck & Co., Inc., stock.
Table 1. Summary of Confirmed Thrombotic Cardiovascular Serious Adverse Experiences in the ADVANTAGE Trial
Table 2. Summary of the Antiplatelet Trialists' Collaboration Combined End Point in the ADVANTAGE Trial
Braunstein N, Polis A. Report of Specific Cardiovascular Outcomes of the ADVANTAGE Trial. Ann Intern Med. 2005;143:158–159. doi: https://doi.org/10.7326/0003-4819-143-2-200507190-00118
Download citation file:
Published: Ann Intern Med. 2005;143(2):158-159.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use